Highland Capital Management (Texas)’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Highland Capital Management (Texas)’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$4.61M	Sell	1,153,993 -1,263,000	-52%	-$6.01M	0.27%	64
2019 Q1	$13M	Buy	2,416,993 +25,000	+1%	+$161K	0.81%	21
2018 Q4	$12.3M	Sell	2,391,993 -262,435	-10%	-$1.99M	0.94%	16
2018 Q3	$25.7M	Buy	2,654,428 +736,550	+38%	+$7.43M	1.42%	13
2018 Q2	$19.6M	Buy	1,917,878 +958,600	+100%	+$10.8M	1.11%	19
2018 Q1	$12.5M	Buy	959,278 +731,378	+321%	+$10.9M	0.64%	35
2017 Q4	$4.08M	Buy	227,900 +179,800	+374%	+$3.75M	0.19%	111
2017 Q3	$1.21M	Buy	+48,100	New	+$1.12M	0.05%	181
2017 Q2	–	Sell	-30,000	Closed	-$577K	–	346
2017 Q1	$577K	Buy	+30,000	New	+$473K	0.03%	222
2016 Q3	–	Sell	-75,000	Closed	-$1.04M	–	375
2016 Q2	$1.04M	Buy	+75,000	New	+$1.1M	0.04%	187

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highland Capital Management (Texas)'s PRTK Position: Q2 2019 in Review

Highland Capital Management (Texas) reduced its Paratek Pharmaceuticals, Inc. (PRTK) stake by 52% in Q2 2019, selling an estimated $6.01M and leaving 1,153,993 shares worth $4.61M. The position accounts for 0.27% of the portfolio, ranked #64.

Highland Capital Management (Texas) first reported a position in PRTK in Q2 2016 and has held it in 10 quarters since. The position peaked at $25.7M in Q3 2018. 89 funds tracked by Wall St. Rank hold PRTK as of Q2 2019.

Highland Capital Management (Texas) held 1,153,993 shares of Paratek Pharmaceuticals, Inc. worth $4.61M as of Q2 2019.
Highland Capital Management (Texas) sold 1,263,000 Paratek Pharmaceuticals, Inc. shares in Q2 2019, an estimated $6.01M.
Paratek Pharmaceuticals, Inc. made up 0.27% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #64 holding.
Highland Capital Management (Texas) first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2016 and has held it in 10 quarters since.
Highland Capital Management (Texas)'s Paratek Pharmaceuticals, Inc. position peaked at $25.7M in Q3 2018.
89 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.